C Hauser Selected Research

C Hauser Research Topics

Disease

6	Neoplasms (Cancer) 01/2017 - 08/2000
4	Infections 01/2014 - 09/2000
4	Anaphylaxis (Anaphylactic Shock) 04/2011 - 05/2000
2	Urticaria (Hives) 06/2008 - 07/2006
2	Seasonal Allergic Rhinitis (Hay Fever) 06/2008 - 09/2005
2	Asthma (Bronchial Asthma) 04/2007 - 09/2005
2	Hypersensitivity (Allergy) 09/2005 - 01/2001
2	Eosinophilia 01/2005 - 06/2000
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022
1	Renal Insufficiency (Renal Failure) 03/2020
1	Peritonitis 04/2016
1	Fistula 04/2016
1	Adenocarcinoma 10/2014
1	Necrosis 10/2014
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2014
1	Hemorrhage 10/2013
1	Lactic Acidosis 10/2013
1	Multiple Organ Failure (MODS) 10/2013
1	Wounds and Injuries (Trauma) 10/2013
1	Immediate Hypersensitivity 04/2011
1	Parkinson Disease (Parkinson's Disease) 01/2005
1	Panniculitis 01/2005
1	Endometrial Neoplasms (Endometrial Cancer) 01/2003
1	Carcinoma (Carcinomatosis) 01/2003
1	Contact Dermatitis (Eczema, Contact) 12/2002
1	Autoimmune Diseases of the Nervous System 08/2001
1	Food Hypersensitivity (Food Allergy) 03/2001
1	Latex Hypersensitivity (Latex Allergy) 01/2001
1	Hemorrhagic Shock 10/2000
1	Craniocerebral Trauma (Head Injury) 10/2000
1	Human Influenza (Influenza) 08/2000
1	Melanoma (Melanoma, Malignant) 08/2000
1	Angioedema 06/2000
1	Virus Diseases (Viral Diseases) 05/2000
1	Squamous Cell Carcinoma of Head and Neck 01/2000
1	Aneuploidy (Aneuploid) 01/2000

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 04/2007 - 10/2000
2	CytokinesIBA 12/2002 - 09/2000
2	AntigensIBA 03/2001 - 08/2000
1	Pharmaceutical PreparationsIBA 01/2022
1	Cefepime (Maxipime)FDA LinkGeneric 03/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Laminin (Merosin)IBA 01/2017
1	Granzymes (Granzyme)IBA 01/2017
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2017
1	Angiogenesis InhibitorsIBA 01/2017
1	VitronectinIBA 01/2017
1	Death Domain ReceptorsIBA 10/2014
1	LigandsIBA 10/2014
1	Rituximab (Mabthera)FDA Link 01/2014
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2013
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	Local Anti-Infective Agents (Antiseptics)IBA 04/2011
1	anti-IgE antibodiesIBA 04/2007
1	Omalizumab (Xolair)FDA Link 04/2007
1	Cholinergic Agents (Cholinergics)IBA 07/2006
1	ragweed pollenIBA 09/2005
1	Apomorphine FDA Link 01/2005
1	SteroidsIBA 01/2003
1	CyclodextrinsIBA 01/2003
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 01/2003
1	Steroid Receptors (Steroid Receptor)IBA 01/2003
1	CholesterolIBA 01/2003
1	Irritants (Vesicants)IBA 12/2002
1	Myelin-Oligodendrocyte GlycoproteinIBA 08/2001
1	LipopolysaccharidesIBA 08/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2001
1	Interferon-alpha (Interferon Alfa)IBA 08/2001
1	CD40 Ligand (CD40L)IBA 08/2001
1	oxybenzone (Solbar)FDA Link 03/2001
1	Sunscreening Agents (Sunscreens)IBA 03/2001
1	AllergensIBA 03/2001
1	CarrageenanIBA 03/2001
1	LatexIBA 01/2001
1	Immunoglobulin E (IgE)IBA 01/2001
1	beta-Galactosidase (Lactaid)IBA 09/2000
1	Peptides (Polypeptides)IBA 08/2000
1	Immunoglobulin M (IgM)IBA 06/2000
1	LymphokinesIBA 05/2000
1	Inulin FDA Link 05/2000
1	Genetic Markers (Genetic Marker)IBA 01/2000
1	DNA ProbesIBA 01/2000
1	DNA (Deoxyribonucleic Acid)IBA 01/2000

Therapy/Procedure

5	Therapeutics 01/2017 - 08/2000
2	Resuscitation 10/2013 - 10/2000
2	Immunotherapy 06/2008 - 09/2000
1	Enteral Nutrition (Feeding, Tube) 04/2016
1	Esophagectomy 10/2015
1	Neoadjuvant Therapy 10/2015
1	Remission Induction 01/2014
1	Mechanical Ventilators (Ventilator) 10/2013
1	Renal Dialysis (Hemodialysis) 07/2006
1	Cardiopulmonary Resuscitation (CPR) 10/2000